STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

Active, not recruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2025

Study Completion Date

December 31, 2025

Conditions
Risk ReductionOvarian Cancer
Interventions
PROCEDURE

Opportunistic Salpingectomy

An opportunistic salpingectomy refers to removal of the fallopian tubes without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases.

Trial Locations (27)

5223 GZ

Jeroen Bosch Hospital, 's-Hertogenbosch

1091 AC

OLVG, Amsterdam

1105AZ

Academic Medical Centrum, Amsterdam

6800 TA

Rijnstate Hospital, Arnhem

4818 CK

Amphia hospital, Breda

2625 AD

Reinier de Graaf, Delft

7009 BL

Slingeland Hospital, Doetinchem

3300 AK

Albert Schweitzer hospital, Dordrecht

5623 EJ

Catharina Hospital, Eindhoven

7500 KA

Medical Spectrum Twente, Enschede

9728 NT

Martini hospital, Groningen

2000 AK

Spaarne Gasthuis, Haarlem

7555 DL

Ziekenhuisgroep Twente, Hengelo

8934 AD

Medical Center Leewarden, Leeuwarden

2300 RC

Leids University Medical Center, Leiden

6229 HX

Maastricht University Medical Center, Maastricht

3434 CM

St Antonius, Nieuwegein

6525 GA

Radboud UMC, Nijmegen

6532 SZ

Canisius Wilhelmina Hospital, Nijmegen

3000 CA

Erasmus Medical Center, Rotterdam

2512 VA

Haaglanden Medical Center Westeinde, The Hague

5042 AD

Elisabeth-Tweesteden Hospital, Tilburg

3508 TG

Diakonessenhuis, Utrecht

5500 MB

Maxima Medical Center, Veldhoven

5801 CE

VieCuri Medical Center, Venlo

6001 BE

Sint Jans Gasthuis, Weert

8025 AB

Isala, Zwolle

All Listed Sponsors
collaborator

Catharina Ziekenhuis Eindhoven

OTHER

lead

Radboud University Medical Center

OTHER

NCT04470921 - STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands | Biotech Hunter | Biotech Hunter